Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: New York NY, Newport News VA, Baltimore MD, York PA,
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase 3, Recruiting
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome
for
Cystitis, Interstitial, Painful Bladder Syndrome
Location: Philadelphia PA
Sponsor: Philadelphia Urosurgical Associates
Sex: Female
Age: 18 - 70+
Code: NCT02868775
Recruiting
Functional Lung Imaging in Patients With Respiratory Compromise Undergoing Endobronchial Valve Placement
for
Emphysema
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 40+
Code: NCT05204875
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections
for
Osteo Arthritis of Hip
Location: Philadelphia PA
Sponsor: Rothman Institute Orthopaedics
Sex: All
Age: 18+
Code: NCT03647332
Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: K36 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05651932
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer